1.	Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer Phase: Phase III Type: Treatment Status: Active Age: Under 75 Sponsor: Other Protocol IDs: CDR0000416088, FRE-FNCLCC-GETUG-14/0207, EU-20503, NCT00104741
2.	Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000577574, RTOG-0534, NCT00567580
3.	Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000648194, RTOG-0815, NCT00936390
4.	Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000701128, RTOG-0924, NCT01368588
5.	Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: R04-0092, NCT00138918
6.	Intermittent Hormone Therapy in Men With Localized Prostate Cancer After Radiation Therapy or Radical Prostatectomy Phase: Phase II Type: Treatment Status: Active Age: over 21 Sponsor: Other Protocol IDs: 30296-A, L-8863, 06-2040-A-02, NCT00223665
7.	Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 070107, 07-C-0107, NCI-07-C-0107, 7354, NCT00450463